πŸ‡ΊπŸ‡Έ FDA
Patent

US 9994847

miR-29 mimics and uses thereof

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 9994847 (miR-29 mimics and uses thereof) held by MIRAGEN THERAPEUTICS, INC. expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MIRAGEN THERAPEUTICS, INC.
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/7105, A61K31/713, A61K9/0073, A61K9/0075